Search
for
Sort by
Research 241–270 of 431
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- JAK Inhibitors for Treatment of Alopecia Areata
- The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Ruxolitinib found to cause eyelash growth: a case report
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Pathogenesis of graft-versus-host-disease
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Trace element zinc and skin disorders
- Azathioprine‐induced severe myelosuppression accompanied by massive hair loss and painful oral ulcer in an autoimmune hepatitis patient with <i>NUDT15</i> minor variant: A case report
- Kerion celsi due to <i>Microsporum audouinii</i>: a severe form in an immunocompetent girl
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Case Report: Rare aplastic anemia in pediatric systemic lupus erythematosus: a case series and systematic literature review
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Case report: NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review
- Antioxidant and Antiproliferative Activity of Finasteride against Glioblastoma Cells
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Mechanism-Based Strategies for Prevention of Taxane-Induced Hair Follicle Damage in Cancer Chemotherapy